Study of Mahalakshmi Vilas Ras with standard Treatment in Patients with Headache After Spinal Injection

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2026
INTERVENTION: CONDITION: Health Condition 1: G970‐ Cerebrospinal fluid leak from spinal puncture PRIMARY OUTCOME: 1.Reduction in severity of post‐spinal headache in patients receiving ; Mahalakshmi Vilas Ras with standard treatment compared to those receiving standard ; treatment alone. ; ; 2.effect of Mahalakshmi vilas ras as an add on to standard treatment in ; reducing giddiness compared to standard treatment alone in PSH ; Timepoint: 3 DAYS SECONDARY OUTCOME: 1.Effect of Mahalakshmi vilas ras as an add on to standard treatment in reducing ; nausea and vomiting compared to standard treatment alone in PSH ; Timepoint: 3 DAYS INCLUSION CRITERIA: 1. Age: 20‐50 years. 2. Diagnosis: Clinically confirmed Post‐Spinal Headache (PSH) based on ICHD ‐3 Criteria 3. Patient must undergone : Spinal anesthesia or lumbar puncture within 72 hrs 4. Symptom Onset: Headache onset within 72 hrs post‐procedure 5. Health Status: Hemodynamically stable; no urgent neuro/systemic illness. 6. Gender: Both males and females eligible.
Epistemonikos ID: 760235ad0e3c0466a62a5a0e211fbe2584a75730
First added on: May 09, 2026